Aerometrex Reviews Strategic Options, Including Potential Corporate Transactions
AMX: $0.310 +3.33% · MC: $38M
Aerometrex has engaged advisers to review options ranging from standalone growth to potential transactions involving all or part of its business. The review also covers alternative corporate and capital structures, following improved financial and operating performance and growth in MetroMap recurring revenue. No option has been selected, and there is no certainty of a transaction or structural change.

Comments